Clinical Trial Update: Nebulized Ceftazidime and Amikacin in Ventilator Associated Pneumonia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nebulized ceftazidime and amikacin for ventilator-associated pneumonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventilator-associated Pneumonia

Drugs mentioned

• Amikacin (amikacin)
• ceftazidime (ceftazidime)

Snippet

Sponsor: Groupe Hospitalier Pitie-Salpetriere | Conditions: Pneumonia | Phase 2 | Status: COMPLETED